Exagen's market cap is currently $66.67M. The company's EPS TTM is $-0.938; its P/E ratio is ―; Exagen is scheduled to report earnings on March 24, 2025, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 52.55M	$ 45.56M	$ 48.30M	$ 41.98M	$ 40.39M
Gross Profit	$ 29.46M	$ 21.35M	$ 27.71M	$ 25.42M	$ 21.58M
Operating Income	$ -22.84M	$ -40.55M	$ -24.07M	$ -15.19M	$ -9.30M
EBITDA	$ -19.15M	$ -43.11M	$ -23.10M	$ -13.65M	$ -7.93M
Net Income	$ -23.69M	$ -47.39M	$ -26.85M	$ -16.69M	$ -12.04M
Balance Sheet
Cash & Short-Term Investments	$ 36.49M	$ 62.39M	$ 99.44M	$ 57.45M	$ 72.08M
Total Assets	$ 56.94M	$ 86.22M	$ 123.44M	$ 78.38M	$ 88.31M
Total Debt	$ 23.72M	$ 34.50M	$ 27.48M	$ 26.66M	$ 25.85M
Net Debt	$ -12.77M	$ -27.89M	$ -71.96M	$ -30.79M	$ -46.23M
Total Liabilities	$ 34.25M	$ 43.76M	$ 38.51M	$ 36.54M	$ 32.65M
Stockholders' Equity	$ 22.69M	$ 42.46M	$ 84.94M	$ 41.84M	$ 55.66M
Cash Flow
Free Cash Flow	$ -15.29M	$ -36.46M	$ -22.64M	$ -14.54M	$ -10.11M
Operating Cash Flow	$ -14.46M	$ -32.14M	$ -20.27M	$ -14.08M	$ -9.71M
Investing Cash Flow	$ -804.00K	$ -4.32M	$ -2.42M	$ -455.00K	$ -103.00K
Financing Cash Flow	$ -10.63M	$ -489.00K	$ 64.68M	$ -97.00K	$ 68.73M

Currency in USD

Exagen Earnings and Revenue History

Income Statement >

Exagen Debt to Assets

Balance Sheet >

Exagen Cash Flow

Cash Flow >

Exagen Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing